BOEUF Stock - Bonesupport Holding AB (publ)
Unlock GoAI Insights for BOEUF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $898.73M | $591.08M | $328.82M | $212.88M | $180.86M |
| Gross Profit | $832.25M | $540.92M | $297.71M | $189.70M | $161.60M |
| Gross Margin | 92.6% | 91.5% | 90.5% | 89.1% | 89.4% |
| Operating Income | $166.15M | $13.93M | $-64,535,000 | $-80,669,000 | $-98,561,000 |
| Net Income | $133.75M | $245.02M | $-68,167,000 | $-85,531,000 | $-101,412,000 |
| Net Margin | 14.9% | 41.5% | -20.7% | -40.2% | -56.1% |
| EPS | $2.04 | $3.74 | $-1.06 | $-1.34 | $-1.72 |
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.
Visit WebsiteEarnings History & Surprises
BOEUFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 22, 2026 | — | — | — | — |
Q1 2026 | Feb 23, 2026 | — | — | — | — |
Q4 2025 | Oct 23, 2025 | $0.09 | $0.01 | -93.1% | ✗ MISS |
Q3 2025 | Jul 15, 2025 | $0.08 | $0.08 | +6.7% | ✓ BEAT |
Q2 2025 | Apr 23, 2025 | — | $0.02 | — | — |
Q1 2025 | Feb 25, 2025 | — | $0.07 | — | — |
Q4 2024 | Oct 24, 2024 | — | $0.04 | — | — |
Q3 2024 | Jul 11, 2024 | — | $0.04 | — | — |
Q2 2024 | Apr 25, 2024 | — | $0.03 | — | — |
Q1 2024 | Feb 15, 2024 | — | $0.02 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.32 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.00 | — | — |
Q1 2023 | Feb 16, 2023 | — | $-0.03 | — | — |
Q4 2022 | Oct 27, 2022 | — | $-0.02 | — | — |
Q3 2022 | Jul 14, 2022 | — | $-0.25 | — | — |
Q2 2022 | May 4, 2022 | — | $-0.03 | — | — |
Q1 2022 | Feb 17, 2022 | — | $-0.04 | — | — |
Q4 2021 | Nov 4, 2021 | — | $-0.02 | — | — |
Q3 2021 | Jul 15, 2021 | — | $-0.05 | — | — |
Latest News
Frequently Asked Questions about BOEUF
What is BOEUF's current stock price?
What is the analyst price target for BOEUF?
What sector is Bonesupport Holding AB (publ) in?
What is BOEUF's market cap?
Does BOEUF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BOEUF for comparison